More about

Aspirin

News
September 21, 2021
1 min read
Save

STROKE-VT

STROKE-VT

Direct oral anticoagulants vs. aspirin in patients needing ablation for ventricular tachycardia.

News
September 21, 2021
1 min read
Save

MASTER DAPT

MASTER DAPT

Dual antiplatelet therapy for 1 month vs. 3 or more months in patients at high bleeding risk who had PCI with a biodegradable-polymer sirolimus-eluting stent (Ultimaster, Terumo).

News
September 02, 2021
3 min read
Save

STOPDAPT-2 ACS trial inconclusive for 1- vs. 12-month DAPT after PCI and DES implantation

STOPDAPT-2 ACS trial inconclusive for 1- vs. 12-month DAPT after PCI and DES implantation

Despite fewer bleeding events, 1-month dual antiplatelet therapy with clopidogrel failed to prove noninferiority vs. 12-month DAPT after PCI and stent implantation for ACS, according to a presenter.

News
August 28, 2021
2 min read
Save

DAPT for 1 month after PCI safe, effective in patients at high bleeding risk: MASTER DAPT

DAPT for 1 month after PCI safe, effective in patients at high bleeding risk: MASTER DAPT

In patients at high bleeding risk, dual antiplatelet therapy for 1 month after PCI lowered bleeding rates and was noninferior for ischemic events compared with 3-month DAPT, according to results of the MASTER DAPT trial.

News
August 13, 2021
1 min read
Save

Lower prosthetic joint infection rate seen with aspirin thromboprophylaxis vs other agents

Lower prosthetic joint infection rate seen with aspirin thromboprophylaxis vs other agents

Results of a study showed aspirin was linked with lower rates of early, deep prosthetic joint infection after primary total knee arthroplasty vs. non-aspirin chemoprophylaxis, a presenter said.

News
July 29, 2021
2 min read
Save

STROKE-VT: DOACs superior to aspirin at stroke prevention after LV arrhythmia ablation

STROKE-VT: DOACs superior to aspirin at stroke prevention after LV arrhythmia ablation

Among patients who underwent left ventricular arrhythmia ablation with a radiofrequency catheter, direct oral anticoagulants were superior to aspirin in preventing cerebrovascular events, according to the results of the STROKE-VT trial.

News
July 24, 2021
2 min read
Save

‘ABCs’ of primary and secondary CVD prevention have expanded over the years

‘ABCs’ of primary and secondary CVD prevention have expanded over the years

The “ABCs” have provided a roadmap for primary and secondary CVD prevention since 1999, according to a speaker at the virtual American Society for Preventive Cardiology Congress on CVD Prevention.

News
July 15, 2021
2 min read
Save

AGA publishes clinical practice update on chemoprevention of colorectal neoplasia

AGA publishes clinical practice update on chemoprevention of colorectal neoplasia

The American Gastroenterological Association published a clinical practice update to describe the role of medications for the chemoprevention of colorectal neoplasia.

News
July 15, 2021
11 min read
Save

ADAPTABLE points to solutions about aspirin dose, conduct of pragmatic trials

ADAPTABLE points to solutions about aspirin dose, conduct of pragmatic trials

The ADAPTABLE trial, presented and published in May, was notable in two ways: It provided answers on aspirin dosage for patients needing secondary CVD prevention and it showed a large-scale pragmatic trial could work.

News
July 13, 2021
2 min read
Save

TWILIGHT: Ticagrelor monotherapy 3 months post-PCI decreases bleeding regardless of age

TWILIGHT: Ticagrelor monotherapy 3 months post-PCI decreases bleeding regardless of age

Regardless of patient age, switching from dual antiplatelet therapy to ticagrelor monotherapy after 3 months of ticagrelor plus aspirin reduces bleeding without increasing ischemic events, according to new data from the TWILIGHT trial.

View more